Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33

American Journal of Human Genetics

Volumn 63, Issue 4, 1998, Pages 1086-1094

  Rioux, John D ^a   Stone, Valerie A ^a   Daly, Mark J ^a   Cargill, Michele ^a   Green, Todd ^a   Nguyen, Huy ^a   Nutman, Thomas ^b   Zimmerman, Peter A ^b   Tucker, Margaret A ^c   Hudson, Thomas ^a   Goldstein, Alisa M ^c   Lander, Eric ^a   Lin, Albert Y ^c  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHROMOSOME 5Q; CLINICAL ARTICLE; EOSINOPHILIA; GENE LOCUS; GENE MAPPING; GENETIC ANALYSIS; GENETIC LINKAGE; GENOTYPE; HUMAN; PEDIGREE; PRIORITY JOURNAL;

EID: 0032231916     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302053     Document Type: Article

References (55)

1. Baranger L, Szapiro N, Gardais J, Hillion J, Derre J, Francois S, Blanchet O, et al (1994) Translocation t(5;12)(q31-q33;p12-p13): a nonrandom translocation asociated with a myeloid disorder with eosinophilia. Br J Haematol 88: 343-347
2. Baumgarten E, Wegner RD, Fengler R, Ludwig WD, Schulte-Overberg U, Domeyer C, Schuurmann J, et al (1989) Calla-positive acute leukemia with t(5q;14q) translocation and hypereosinophilia: a unique entity? Acta Haematol 82: 85-90
3. Berkowicz M, Rosner E, Rechavi G, Mamon Z, Neuman Y, Ben-Basat I, Ramot B (1991) Atypical chronic myelomonocytic leukemia with eosinophilia and translocation (5;12): a new association? Cancer Genet Cytogenet 51:277-278
4. Broide DH, Paine MM, Firestein GS (1992) Eosinophils express interleukin 5 and granulocyte macrophage colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J Clin Invest 90:1414-1424
5. Chihara J, Plumas J, Gruart V, Tavernier J, Prin L, Capron A, Capron M (1990) Characterization of a receptor for interleukin 5 on human eosinophils: variable expression and induction by granulocyte/macrophage colony-stimulating factor. J Exp Med 172:1347-1351
6. Chusid MJ, Dale DC, West BC, Wolff SM (1975) The hyper-eosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54:1-27
7. Cockerill PN, Osbourne CS, Bert AG, Grotto RJM (1996) Regulation of GM-CSF gene transcription by core-binding factor. Cell Growth Differ 7:917-922
8. Cockerill PN, Shannon MF, Bert AG, Ryan GR, Vadas MA (1993) The granulocyte-macrophage colony-stimulating factor/interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer. Proc Natl Acad Sci USA 90: 2466-2470
9. Cousins DJ, Staynov DZ, Lee TH (1994) Regulation of interleukin-5 and granulocyte-macrophage colony-stimulating factor expresion. Am J Respir Crit Care Med 150:S50-S53
10. Dent LA, Strath M, Mellor AL, Sanderson CJ (1990) Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med 172:1425-1431
11. Desreumaux P, Janin A, Dubucquoi S, Copin MC, Torpier G, Capron A, Capron M, et al (1993) Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases. Blood 82:1553-1560
12. Desreumaux P, Janin A, Columbel JF, Prin L, Plumas J, Emilie D, Torpier G, et al (1992) Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J Exp Med 175:293-296
13. Dubovsky J, Sheffield VC, Duyk GM, Weber JL (1995) Sets of short tandem repeat polymorphisms for efficient linkage screening of the human genome. Hum Mol Genet 4:449-452
14. Engeland K, Andrews NC, Mathey-Prevot B (1995) Multiple proteins interact with the nuclear inhibitory protein repressor element in the human interleukin-3 promoter. J Biol Chem 270:24572-24579
15. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH (1982) The idiopathic hypereosinophilic syndrome: clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 97:78-92
16. Fermand J, Mitjavila M, Le Couedic J, Tsapis A, Berger R, Modigliani R, Seligmann M, et al (1993) Role of the granulocyte-macrophage colony-stimulating factor, interleukin-3 and interleukin-5 in the eosinophilia associated with T cell lymphoma. Br J Haematol 83:359-364
17. Gaugain M (1909) Un cas d'eosinophilie familiale. Semin Med 29:329
18. Goh KO, Ho FCS, Tso SC, Ma J (1985) Is hypereosinophilic syndrome a malignant disease? Cancer 55:2395-2399
19. Gruart-Gouilleux V, Engels P, Sullivan M (1995) Characterization of the human interleukin-5 gene promoter: involvement of octamer binding sites in the gene promoter activity. Eur J Immunol 25:1431-1435
20. Hardy WR, Anderson RE (1968) The hypereosinophilic syndromes. Ann Intern Med 68:1220-1229
21. Hawkins TL, O'Connor-Morin T, Roy A, Santillan C (1994) DNA purification and isolation using a solid phase. Nucleic Acids Res 22:4543-4544
22. Hogan TF, Koss W, Murgo AJ, Amato RS, Fontana JA, VanScoy FL (1987) Acute lymphoblastic leukemia with chromosomal 5;14 translocation and hypereosinophilia: case report and literature review. J Clin Oncol 5:382-390
23. Jani K, Kempski HM, Reeves BR (1994) A case of myelo-dysplasia with eosinophilia having a translocation t(5; 12)(q31;q13) restricted to myeloid cells but not involving eosinophils. Br J Haematol 87:57-60
24. Karlen S, D'Ercole M, Sanderson CJ (1996a) Two pathways can activate the interleukin-5 gene and induce binding to the conserved lymphokine element 0. Blood 88:211-221
25. Karlen S, Mordvinov VA, Sanderson CJ (1996b) How is expression of the interleukin-5 gene regulated? Immunol Cell Biol 74:218-223
26. Kita H, Ohnishi T, Okubo Y, Weiler D, Abrams JS, Gleich GJ (1991) Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med 174:745-748
27. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES (1996) Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 58:1347-1363
28. Lathrop GM, Lalouel JM, Julier C, Ott J (1984) Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci USA 81:3443-3446
29. Lee NA, McGarry MP, Larson KA, Horton MA, Kristensen AB, Lee JJ (1997) Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extra-medullary eosinophilopoiesis, and unique histopathologies. J Immunol 158:1332-1344
30. Lin AY, Nutman TB, Kaslow D, Mulvilhill JJ, Fontaine L, White BJ, Knutsen T, et al (1998) Familial eosinophilia: clinical and laboratory results on a USA kindred. Am J Med Genet 76:229-237
31. Lopez AF, Eglinton JM, Gillis D, Park LS, Clark S, Vadas MA (1989) Reciprocal inhibition of binding between interleukin 3 and granulocyte-macrophage colony-stimulating factor to human eosinophils. Proc Natl Acad Sci USA 86:7022-7026
32. Matsushima T, Murakami H, Tsuchiya J (1994) Myelodys-plastic syndrome with bone marrow eosinophilia: clinical and cytogenetic features. Leuk Lymphoma 15:491-497
33. Miyatake S, Otsuka T, Yokota T, Lee F, Arai K (1985) Structure of the chromosomal gene for granulocyte-macrophage colony stimulating factor: comparison of the mouse and human genes. EMBO J 4:2561-2568
34. Moqbel R, Hamid Q, Ying S, Barkans J, Hartnell A, Tsico-poulos A, Wardlaw AJ, et al (1991) Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimluating factor in activated human eosinophils. J Exp Med 174:749-752
35. Murray JC, Buetow KH, Weber Ludwigsen S, Heddeema TS, Manion F, Quillen J, Sheffield VC, et al (1994) A comprehensive human linkage map with centimorgan density. Science 265:2049-2054
36. Naiman JL, Oski FA, Allen FH, Diamond LK (1964) Hereditary eosinophilia: report of a family and review of the literature. Am J Hum Genet 16:195-203
37. Nimer S, Zhang J, Avraham H, Miyazaki Y (1996) Transcriptional regulation of interleukin-3 expression in megakaryocytes. Blood 88:66-74
38. O'Connell JR, Weeks DE (1995) The VITESSE algorithm for rapid exact multilocus linkage analysis via genotype set-recording and fuzzy inheritance. Nat Genet 11:402-408
39. Owen WF Jr, Rothenberg ME, Peterson J, Weller PF, Silberstein D, Sheffer AL, Stevens RL, et al (1989) Interlukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med 170:343-348
40. Owen WF Jr, Rothenberg ME, Silberstein DS, Gasson JC, Stevens RL, Austen KF, Soberman RJ (1987) Regulation of human eosinophil viability, density and function by granulocyte/macrophage colony-stimulating factor in the presence of 3t3 fibroblasts. J Exp Med 166:129-141
41. Parrillo JE, Fauci AS, Wolff SM (1978) Therapy of the hypereosinophilic syndrome. Ann Intern Med 89:167-172
42. Rothenberg ME, Owen WF Jr, Silberstein DS, Woods J, Soberman RJ, Austen KF, Stevens RL (1988) Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3. J Clin Invest 81:1986-1992
43. Rothenberg ME, Peterson J, Stevens RL, Silberstein DS, McKenzie DT, Austen KF, Owen WF Jr (1989) IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity. J Immunol 143:2311-2316
44. Sanderson CJ (1992) Interleukin-5, eosinophils, and disease. Blood 79:3101-3109
45. Schrezenmeier H, Thome SD, Tewald F, Fleischer B, Ragavachar A (1993) Interleukin-5 is the predominant eosinophil-opoietin produced by cloned T lymphocytes in hypereosinophilic syndrome. Exp Hematol 21:358-365
46. Schuler GD, Boguski MS, Stewart EA, Stein LD, Gyapay G, Rice K, White RE, et al (1996) A gene map of the human genome. Science 274:540-546
47. Staden R (1996) The Staden sequence analysis package. Mol Biotechnol 5:233-241
48. Staynov DZ, Cousins DJ, Lee TH (1995) A regulatory element in the promoter of the human granulocyte-macrophage colony-stimulating factor gene that has related sequences in other T-cell-expressed cytokine genes. Proc Natl Acad Sci USA 92:3606-3610
49. Stranick KS, Zambas DN, Uss AS, Egan RW, Billah MM, Umland SP (1997) Identification of the transcription factor binding sites important in the regulation of the interleukin-5 gene. J Biol Chem 272:16453-16465
50. Taylor DS, Laubach JR, Nathan DG, Mathey-Prevot B (1996) Cooperation between core binding factor and adjacent promoter elements contributes to the tissue-specific expression of interleukin-3. J Biol Chem 271:14020-14027
51. Vaux DL, Lalor PA, Gory S, Johnson GR (1990) In vivo expression of inrerleukin 5 induces an eosinophilia and expanded Ly-1B lineage populations. Int Immunol 2:965-971
52. Wang C, Bassuk AG, Boise LH, Thompson CB, Bravo R, Leiden JM (1994) Activation of the granulocyte-macrophage colony-stimulating factor promoter in T cells requires cooperative binding of Elf-1 and AP-1 transcription factors. Mol Cell Biol 14:1153-1159
53. Weller PF (1991) The immunobiology of eosinophils. N Engl J Med 324:1110-1118
54. Yamagata T, Nishida J, Sakai R, Tanaka T, Honda H, Hirano N, Mano H, et al (1995) Of the GATA-binding proteins, only GATA-4 selectively regulates the human interleukin-5 gene promter in interleukin-5-producing cells which express multiple GATA-binding proteins. Mol Cell Biol 15: 3830-3839
55. Yates P, Potter MN (1991) Eosinophilic leukemia with an abnormality of 5q31, the site of the IL-5 gene. Clin Lab Haematol 13:211-215